首页> 美国卫生研究院文献>Asian Journal of Andrology >Application of histone modification in the risk prediction of the biochemical recurrence after radical prostatectomy
【2h】

Application of histone modification in the risk prediction of the biochemical recurrence after radical prostatectomy

机译:组蛋白修饰在前列腺癌根治术后生化复发风险预测中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The role of histone modifications in the development and progression of cancer remains unclear. Here, we gave an investigation of the relationship between the various histone modifications and the risk prediction of the biochemical recurrence after radical prostatectomy (RP). Histone 3 lysine 4 dimethylation (H3K4diMe), trimethylation (H3K4triMe), lysine 36 trimethylation (H3K36triMe), histone 4 lysine 20 trimethylation (H4K20triMe) and acetylation of histome 3 lysine 9 (H3K9Ac) were evaluated using immnuohistochemistry coupled with the tissue microarray technique in 169 primary prostatectomy tissue samples. Recursive partitioning analysis (RPA) was used to analyze the data. Through global histone modification analysis in patients who underwent radical prostatectomy, we found that H3K4triMe can predict the risk of the biochemical recurrence for the low grade prostate cancer (Gleason score ≤ 6) after RP. In the case of high grade prostate cancer (Gleason score ≥ 7), H4K20triMe and H3K9Ac accompanying with the pre-operation prostate-specific antigen (PSA) level could also predict the risk of the biochemical recurrence after RP. In combination with the Gleason score and pre-operation PSA level, the acetylation and methylation of histones H3 and H4 can predict the biochemical recurrence of the prostate cancer following RP.
机译:组蛋白修饰在癌症发生和发展中的作用尚不清楚。在这里,我们对根治性前列腺切除术(RP)后各种组蛋白修饰与生化复发风险预测之间的关系进行了研究。使用immnuohistoarray技术结合组蛋白微阵列技术评估了组蛋白3赖氨酸4的二甲基化(H3K4diMe),三甲基化(H3K4triMe),赖氨酸36的三甲基化(H3K36triMe),组蛋白4赖氨酸20的三甲基化(H4K20triMe)和组蛋白3赖氨酸9的乙酰化(H3K9Ac)。 169份前列腺原发切除组织样本。递归分区分析(RPA)用于分析数据。通过对接受根治性前列腺切除术的患者进行的整体组蛋白修饰分析,我们发现H3K4triMe可以预测RP后低度前列腺癌(格里森评分≤6)的生化复发风险。对于高级别前列腺癌(格里森评分≥7),H4K20triMe和H3K9Ac伴有术前前列腺特异性抗原(PSA)水平也可以预测RP后生化复发的风险。结合格里森评分和术前PSA水平,组蛋白H3和H4的乙酰化和甲基化可以预测RP后前列腺癌的生化复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号